Robin McDougall

Associate Director, DMPK, Translational PKPD Modeling at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Robin McDougall's Colleagues at Alnylam Pharmaceuticals
Heather PharmD

Sr Director, Medical Information & Review, Medical Affairs

Contact Heather PharmD

Jennifer PharmD

Director, US Advertising & Promotion, Regulatory Affairs

Contact Jennifer PharmD

Caitlin Cooper

Director, Business Development

Contact Caitlin Cooper

Rhonda MBA

Regional Business Director

Contact Rhonda MBA

Allison PharmD

Associate Director, Global Patient Safety & Risk Management

Contact Allison PharmD

Benjamin Stevens

Director Regulatory Affairs CMC

Contact Benjamin Stevens

Jason Costigan

Director, Global CMC Lead

Contact Jason Costigan

View All Robin McDougall's Colleagues
Robin McDougall's Contact Details
HQ
(617) 551-8200
Location
Company
Alnylam Pharmaceuticals
Robin McDougall's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Robin McDougall
Robin McDougall currently works for Alnylam Pharmaceuticals.
Robin McDougall's role at Alnylam Pharmaceuticals is Associate Director, DMPK, Translational PKPD Modeling.
Robin McDougall's email address is ***@alnylam.com. To view Robin McDougall's full email address, please signup to ConnectPlex.
Robin McDougall works in the SaaS industry.
Robin McDougall's colleagues at Alnylam Pharmaceuticals are Heather PharmD, Jennifer PharmD, Caitlin Cooper, Rhonda MBA, Allison PharmD, Benjamin Stevens, Jason Costigan and others.
Robin McDougall's phone number is (617) 551-8200
See more information about Robin McDougall